ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

GANX Gain Therapeutics Inc

2,50
0,16 (6,84%)
Após o horário de negociação
Última atualização: 20:18:42
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Gain Therapeutics Inc GANX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,16 6,84% 2,50 20:18:42
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,28 2,16 2,4679 2,20 2,34
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202408:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
14/05/202408:30GLOBEGain Therapeutics Reports Financial Results for First..
24/04/202410:25GLOBEGain Therapeutics Announces Positive Results from the Single..
08/04/202410:25GLOBEGain Therapeutics Bolsters Management Team with the..
01/04/202410:25GLOBEGain Therapeutics Strengthens Management Team and Appoints..
26/03/202409:00GLOBEGain Therapeutics Reports Financial Results for Year End..
15/03/202415:30GLOBEGain Therapeutics to Present at Public Ventures Discovery..
05/03/202410:00GLOBEGain Therapeutics Presents Data at the AD/PD™ 2024..
27/02/202416:00GLOBEGain Therapeutics Announces the Initiation of the Multiple..
14/02/202414:29GLOBEGain Therapeutics Announces 2024 R&D Update on Parkinson’s..
06/02/202411:56GLOBEUPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
06/02/202410:00GLOBEGain Therapeutics’ GT-02287 Completely Restores Motor..
31/01/202410:00GLOBEGain Therapeutics’ CEO Matthias Alder Issues Letter to..
02/01/202410:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
01/12/202310:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
29/11/202310:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
24/11/202315:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
21/11/202310:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
20/11/202318:03GLOBEGain Therapeutics Announces Proposed Public Offering
14/11/202309:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
04/10/202308:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
25/09/202317:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
20/09/202317:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
12/09/202310:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
10/08/202308:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
07/08/202308:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
31/07/202309:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..